rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-10-27
|
pubmed:abstractText |
Amino-bisphosphonates are potent activators of human gammadelta T cells. The aim of our study was to evaluate the immunomodulating properties of a single-dose of zoledronic acid (ZA) on gammadelta T cells in a select group of disease-free breast cancer patients with osteopenia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1432-0851
|
pubmed:author |
pubmed-author:AgratiChiaraC,
pubmed-author:FrattoMaria ElisabettaME,
pubmed-author:GalluzzoSaraS,
pubmed-author:ManavalanJohn SJS,
pubmed-author:MartiniFedericoF,
pubmed-author:PiacentiniPaolaP,
pubmed-author:PocciaFabrizioF,
pubmed-author:RocciLauraL,
pubmed-author:SantiniDanieleD,
pubmed-author:ToniniGiuseppeG,
pubmed-author:TurchiFedericaF,
pubmed-author:VincenziBrunoB
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-8
|
pubmed:meshHeading |
pubmed-meshheading:18458903-Aged,
pubmed-meshheading:18458903-Aged, 80 and over,
pubmed-meshheading:18458903-Antineoplastic Agents,
pubmed-meshheading:18458903-Breast Neoplasms,
pubmed-meshheading:18458903-Diphosphonates,
pubmed-meshheading:18458903-Female,
pubmed-meshheading:18458903-Humans,
pubmed-meshheading:18458903-Imidazoles,
pubmed-meshheading:18458903-Lymphocyte Subsets,
pubmed-meshheading:18458903-Middle Aged,
pubmed-meshheading:18458903-Neoplasm Staging,
pubmed-meshheading:18458903-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:18458903-T-Lymphocytes
|
pubmed:year |
2009
|
pubmed:articleTitle |
In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.
|
pubmed:affiliation |
Medical Oncology, University Campus Bio-Medico, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|